Zelixir Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14.5M
- Investors
-
10
Zelixir General Information
Description
Developer of biobased manufacturing technology designed for synthetic biology. The company utilizes artificial intelligence and synthetic biology to produce natural vanillin, biobased raw materials, protein modeling tools, enzyme reaction extractors, functional food ingredients, and beauty product ingredients, providing food and beverage markets with sustainable alternatives to traditional chemical synthesis.
Contact Information
Website
www.zelixir.comCorporate Office
- 4th Floor, Youyue International, Number 298 Xiangke Road, Zhangjiang High-Tech Park
- Pudong New Area
- Shanghai, 201203
- China
Corporate Office
- 4th Floor, Youyue International, Number 298 Xiangke Road, Zhangjiang High-Tech Park
- Pudong New Area
- Shanghai, 201203
- China
Zelixir Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 27-Apr-2023 | $14.5M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 01-Aug-2021 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Jul-2021 | Completed | Startup |
Zelixir Patents
Zelixir Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025241548-A1 | 4-vinylguaiacol oxygenase mutant for synthesizing vanillin, and engineered bacterium thereof | Pending | 23-May-2024 | ||
| WO-2023131206-A1 | Method and apparatus for evaluating bonding strength of complex, and computer device | Inactive | 04-Jan-2022 | ||
| WO-2023116816-A1 | Protein sequence alignment method and apparatus, and server and storage medium | Inactive | 23-Dec-2021 |
Zelixir Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ally Bridge Group | Growth/Expansion | Minority | ||
| Heda Ventures | Venture Capital | Minority | ||
| HM Capital | Venture Capital | Minority | ||
| Hongfeng Capital | Growth/Expansion | Minority | ||
| Lake Bleu Capital | Hedge Fund | Minority |
Zelixir FAQs
-
When was Zelixir founded?
Zelixir was founded in 2021.
-
Where is Zelixir headquartered?
Zelixir is headquartered in Shanghai, China.
-
What industry is Zelixir in?
Zelixir’s primary industry is Biotechnology.
-
Is Zelixir a private or public company?
Zelixir is a Private company.
-
What is Zelixir’s current revenue?
The current revenue for Zelixir is .
-
How much funding has Zelixir raised over time?
Zelixir has raised $14.5M.
-
Who are Zelixir’s investors?
Ally Bridge Group, Heda Ventures, HM Capital, Hongfeng Capital, and Lake Bleu Capital are 5 of 10 investors who have invested in Zelixir.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process